Creative Financial Designs’s Voyager Therapeutics VYGR Stock Holding History

Creative Financial Designs’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$700	Hold	200	–	–	﹤0.01%	2098
2026 Q1	$772	Hold	200	–	–	﹤0.01%	1942
2025 Q4	$786	Hold	200	–	–	﹤0.01%	1842
2025 Q3	$934	Hold	200	–	–	﹤0.01%	1817
2025 Q2	$622	Hold	200	–	–	﹤0.01%	1871
2025 Q1	$676	Hold	200	–	–	﹤0.01%	1866
2024 Q4	$1.13K	Hold	200	–	–	﹤0.01%	1678
2024 Q3	$1.17K	Hold	200	–	–	﹤0.01%	1570
2024 Q2	$1.58K	Hold	200	–	–	﹤0.01%	1508
2024 Q1	$1.86K	Hold	200	–	–	﹤0.01%	1495
2023 Q4	$1.69K	Buy	+200	New	+$1.45K	﹤0.01%	1451

Other funds holding VYGR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Creative Financial Designs's VYGR Position: Q2 2026 in Review

Creative Financial Designs held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 200 shares worth $700. The position accounts for ﹤0.01% of the portfolio, ranked #2098.

Creative Financial Designs first reported a position in VYGR in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.86K in Q1 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

Creative Financial Designs held 200 shares of Voyager Therapeutics worth $700 as of Q2 2026.
Creative Financial Designs left its Voyager Therapeutics share count unchanged in Q2 2026.
Voyager Therapeutics made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #2098 holding.
Creative Financial Designs first reported a position in Voyager Therapeutics in Q4 2023 and has held it in 11 quarters since.
Creative Financial Designs's Voyager Therapeutics position peaked at $1.86K in Q1 2024.
136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.